Intensity Therapeutics Net Income

Intensity Therapeutics (INTS) currently reports a net income of $-11M as of March 2026. That compares with $-15M in the prior-year period — up 28.8% year over year. That is below the sector sector average of $110M. Use the charts on this page to explore Intensity Therapeutics's net income history and peer comparisons.

Intensity Therapeutics's net income increased from $-15M to $-11M — a 28.8% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Intensity Therapeutics's net income of $-11M is lower than the its sector sector average of $110M. That is roughly 110.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Intensity Therapeutics reported $-11M in net income as of March 2026. That compares with $-15M in the prior-year period — up 28.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-11M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $110M. From there, open related valuation or income-statement pages for Intensity Therapeutics, and consider following INTS for alerts when major investors trade the stock.